TrialJournal of thrombosis and haemostasis : JTH2010

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.

N S Ferder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.